在非糖尿病人群中,BAN评分和明显的早期心脏代谢风险特征:横截面分析

相关实验视频

Updated: Jan 16, 2026

07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.2K

Yazeed Alshuweishi¹, Noha A Alshuwayer², Lama Izziddeen³

¹Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia.

Healthcare (Basel, Switzerland)

|September 27, 2025

概括

体重指数-白蛋白-中性粒细胞-淋巴细胞 (BAN) 评分与早期心脏代谢风险有关,如高血压和非糖尿病成年人的血糖变化. 这一分数可能有助于识别患心血管和代谢疾病风险的个体.

科学领域:

心脏病学心脏病学
代谢健康代谢健康
生物标志物生物标志物

背景情况:

体重指数-白蛋白-中性粒细胞-淋巴细胞 (BAN) 评分结合了脂肪,营养状况和炎症.
它在检测非糖尿病人早期心脏代谢变化的实用性尚未得到充分证实.

研究的目的:

调查BAN得分与血管,血糖和脂质标记物之间的关联.
评估BAN得分作为心脏代谢风险早期指标的潜力.

主要方法:

对162名非糖尿病成年人的回顾性横截面研究.
分析包括斯皮尔曼相关性,ROC分析和调整后回归模型.
评估了血管 (SBP,PP),血糖 (HbA1c) 和脂质参数.

主要成果:

较高的BAN分数与缩血压 (SBP),脉冲压 (PP) 和HbA1c的增加相关.
调整后的模型显示,BAN得分的增加与更高的SBP,PP和HbA1c有关.
BAN评分显示了对高血压和HbA1c升高的中度区分能力.

结论:

该BAN得分与早期心脏代谢风险因素有关,包括SBP升高,PP扩大和血糖变化.
需要进一步的研究来阐明BAN得分的潜在机制及其预防策略的潜力.

关键词:

这就是BAN得分.血压血压血压血压心血管疾病的风险.失糖症失糖症失糖症

相关概念视频

01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

800

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

800

01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

395

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

395

01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

540

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

540

01:30

Coronary Artery Disease I: Introduction

882

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

882

01:23

Assessment of the Cardiovascular System I: Subjective Data

755

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

755